Biosensor Technology

Biosensor Technology designates analytical devices combining biological recognition elements including antibodies, enzymes, aptamers, or nucleic acids with physical transducers converting molecular binding events into measurable electrical, optical, or acoustic signals, enabling sensitive, specific, and often real-time detection of biological analytes in complex samples.

The biopharmaceutical industry employs biosensors across diverse applications including drug discovery, bioprocess monitoring, quality control, and clinical diagnostics. Surface plasmon resonance biosensors provide label-free kinetic characterisation of molecular interactions supporting antibody selection and drug target binding studies. Electrochemical biosensors enable real-time monitoring of glucose, lactate, and pH in bioreactor cultures. Lateral flow immunoassay biosensors provide rapid point-of-care diagnostic testing. Wearable biosensors for continuous patient monitoring generate real-world data supporting clinical trials. As sensitivity improves through nanotechnology integration and multiplexing expands simultaneous analyte detection, biosensor technology continues advancing as a versatile analytical platform enabling new measurement capabilities across pharmaceutical development and clinical application.